Keyoniq is a Swiss company connected to leading longevity and tech communities worldwide. We focus on promoting healthy, active living through personalised health management. By combining scientific innovation, clinical expertise, and advanced technology, we empower both professionals and individuals to achieve healthier, longer lives.
Holistic health approach
Blending evidence-based medicine with integrative well-being.
Expert collaboration
Partnering with experts in aging, medicine, and longevity lifestyle.
Talent meets technology
Maximising outcomes with talent, expertise, data science, and technology.
Lifelong health focus
Optimising lifelong health with a comprehensive client journey.
We are a team of skilled experts at the intersection of research, clinical practice, data science, and technology, dedicated to creating a future that promotes long, healthy, and vibrant lives.
KEYONIQ stems from Bumrungrad International Hospital, Southeast Asia’s leading healthcare provider, and VitalLife Scientific Wellness Center. Since its IPO in 1989, Bumrungrad International Hospital has established itself as a top-tier institution in the Asian healthcare sector by consistently delivering exceptional healthcare services.
Prof. Evelyne Bischof, MD, PhD, MPH
Prof. Evelyne Bischof, MD, PhD, MPH, is a Swiss-trained internal medicine and longevity specialist, serving as a professor at Shanghai University of Medicine and Health Sciences and Tel Aviv University. She is Vice President of the Healthy Longevity Medicine Society and Head of the Visionary Board at the Longevity Science Foundation.
Dr. Brian Kennedy, PhD
Dr. Brian Kennedy is a Distinguished Professor of Biochemistry and Physiology at the Yong Loo Lin School of Medicine, National University of Singapore. He directs the Healthy Longevity Translational Research Programme and the Bia-Echo Asia Centre for Reproductive Longevity and Equality.
Dr. Christopher Mason, PhD
Dr. Christopher Mason is a Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine in New York, where he also directs the WorldQuant Initiative for Quantitative Prediction. His work advances the understanding of genetic mechanisms underlying health and longevity.
